CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents ($146,455 and $123,877 restricted at December 31, 2019 and March 31, 2020, respectively)	$ 383,963	$ 325,249
Accounts receivable, net	923,716	890,065
Short-term investments ($318,464 and $329,237 restricted at December 31, 2019 and March 31, 2020, respectively)	350,192	334,489
Pharmaceutical inventory	42,333	44,962
Other current assets ($38,602 and $42,900 restricted at December 31, 2019 and March 31, 2020, respectively)	106,820	78,278
Total Current Assets	1,807,024	1,673,043
Property and equipment, net	143,260	138,422
Long-term investments ($10,111 and $6,178 restricted at December 31, 2019 and March 31, 2020, respectively)	6,289	10,668
Deferred income taxes	698	1,840
Other long-term assets	96,389	82,700
Goodwill	1,018,156	1,018,156
Other intangible assets, net	153,095	167,344
Total Assets	3,224,911	3,092,173
Current Liabilities:
Accounts payable	104,359	88,415
Accrued liabilities	320,826	284,024
Medical claims payable	392,141	409,533
Other medical liabilities	128,454	124,684
Current debt, finance lease and deferred financing obligations	84,402	3,491
Total Current Liabilities	1,030,182	910,147
Long-term debt, finance lease and deferred financing obligations	647,624	679,125
Deferred income taxes	23,235	17,034
Tax contingencies	16,021	14,841
Deferred credits and other long-term liabilities	76,246	73,243
Total Liabilities	1,793,308	1,694,390
STOCKHOLDERS' EQUITY
Preferred stock, par value $.01 per share:Authorized-10,000 shares at December 31, 2019 and March 31, 2020-Issued and outstanding-none
Common stock, par value $.01 per share: Authorized-100,000 shares at December 31, 2019 and March 31, 2020-Issued and outstanding-54,285 and 23,935 shares at December 31, 2019, respectively, and 54,631 and 24,969 shares at March 31, 2020, respectively	546	543
Other Stockholders' Equity:
Additional paid-in capital	1,402,797	1,386,616
Retained earnings	1,493,044	1,475,207
Accumulated other comprehensive (loss) income	(57)	144
Treasury stock, at cost, 29,662 and 29,662 shares at December 31, 2019 and March 31, 2020, respectively	(1,464,727)	(1,464,727)
Total Stockholders' Equity	1,431,603	1,397,783
Total Liabilities and Stockholders' Equity	$ 3,224,911	$ 3,092,173